Italian intersociety consensus on DOAC use in internal medicine.

Abstract

The direct oral anticoagulants (DOACs) are drugs used in clinical practice since 2009 for the prevention of stroke or systemic embolism in non-valvular atrial fibrillation, and for the treatment and secondary prevention of venous thromboembolism. The four DOACs, including the three factor Xa inhibitors (rivaroxaban, apixaban and edoxaban) and one direct… (More)
DOI: 10.1007/s11739-017-1628-6

Topics

15 Figures and Tables

Cite this paper

@article{Prisco2017ItalianIC, title={Italian intersociety consensus on DOAC use in internal medicine.}, author={Domenico Prisco and Walter Ageno and Cecilia Becattini and Armando D'angelo and Giovanni Dav{\'i} and Raimondo de Cristofaro and Francesco Dentali and Giovanni di Minno and Anna Falanga and Gualberto Gussoni and Luca Masotti and Gualtiero Palareti and Pasquale Pignatelli and Roberto Mario Santi and Francesca Santilli and Mauro Silingardi and Antonella Tufano and Francesco Violi}, journal={Internal and emergency medicine}, year={2017}, volume={12 3}, pages={387-406} }